← All publications

Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads

Oduor RO, Ojo KK, Williams GP, … Holler TP · PLoS Negl Trop Dis 2011 · PLoS Negl Trop Dis 5(4):e1017

GSK-3 (HS & Tbru, Ser/Thr) Ser/Thr kinase Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Read the paper View on PubMed

More publications on GSK-3

A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism

Ghazanfari D, Noori MS, Bergmeier SC, … Goetz DJ · Bioorg Med Chem 2021

Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway

Cheng Z, Guo Y, Yang Y, … Liu C · Oncol Rep 2016

Spatially coordinated kinase signaling regulates local axon degeneration

Chen M, Maloney JA, Kallop DY, … Watts RJ · J Neurosci 2012

Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungals

Grütter C, Simard JR, Mayer-Wrangowski SC, … Rauh D · ACS Chem Biol 2012

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis

Xie D, Gore C, Liu J, … Hsieh JT · Proc Natl Acad Sci U S A 2010

AssayQuant Technologies logo

 

 

260 Cedar Hill Street
Marlboro MA 01752

Phone: +1 (508) 804-3155

      

© 2026 AssayQuant Technologies, Inc. - All Rights Reserved - Privacy Policy - Terms & Conditions - FCOI